Skip to main content
Top
Published in: Digestive Diseases and Sciences 2/2024

05-01-2024 | Correspondence

Indications for the Use of Endoscopic Ultrasound-Guided Liver Biopsy in Patients with Liver Fibrosis

Authors: Enver Zerem, Mirela Denjagić Bašić, Admir Kurtcehajic, Dina Zerem, Mirza Imamović, Omar Zerem

Published in: Digestive Diseases and Sciences | Issue 2/2024

Login to get access

Excerpt

Dear Editor, …
Literature
2.
go back to reference Lindor KD, Bru C, Jorgensen RA, Rakela J, Bordas JM, Gross JB, Rodes J, McGill DB, Reading CC, James EM, Charboneau JW, Ludwig J, Batts KP, Zinsmeister AR. The role of ultrasonography and automatic-needle biopsy in outpatient percutaneous liver biopsy. Hepatology 1996;23:1079–1083. https://doi.org/10.1002/hep.510230522.CrossRefPubMed Lindor KD, Bru C, Jorgensen RA, Rakela J, Bordas JM, Gross JB, Rodes J, McGill DB, Reading CC, James EM, Charboneau JW, Ludwig J, Batts KP, Zinsmeister AR. The role of ultrasonography and automatic-needle biopsy in outpatient percutaneous liver biopsy. Hepatology 1996;23:1079–1083. https://​doi.​org/​10.​1002/​hep.​510230522.CrossRefPubMed
7.
go back to reference Zerem E, Salkic N, Jovanovic P. Is it untrue that ultrasonography guidance is superior to the blind method for liver biopsy? J Gastrointestin Liver Dis. 2010;19:339–340.PubMed Zerem E, Salkic N, Jovanovic P. Is it untrue that ultrasonography guidance is superior to the blind method for liver biopsy? J Gastrointestin Liver Dis. 2010;19:339–340.PubMed
9.
go back to reference AkkanCetinkaya Z, Sezikli M, Güzelbulut F, Benek YZ, Ozkara S, Gökden Y, Yaşar B, Ovünç Kurdaş O. Liver biopsy: ultrasonography guidance is not superior to the blind method. J Gastrointestin Liver Dis. 2010;19:49–52. AkkanCetinkaya Z, Sezikli M, Güzelbulut F, Benek YZ, Ozkara S, Gökden Y, Yaşar B, Ovünç Kurdaş O. Liver biopsy: ultrasonography guidance is not superior to the blind method. J Gastrointestin Liver Dis. 2010;19:49–52.
Metadata
Title
Indications for the Use of Endoscopic Ultrasound-Guided Liver Biopsy in Patients with Liver Fibrosis
Authors
Enver Zerem
Mirela Denjagić Bašić
Admir Kurtcehajic
Dina Zerem
Mirza Imamović
Omar Zerem
Publication date
05-01-2024
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 2/2024
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-023-08228-1

Other articles of this Issue 2/2024

Digestive Diseases and Sciences 2/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.